Matinas biopharma to participate in 33rd annual piper sandler virtual healthcare conference

Bedminster, n.j., nov. 18, 2021 (globe newswire) -- matinas biopharma holdings, inc. (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (lnc) platform delivery technology, has been invited to present a company overview at the piper sandler 33rd annual virtual healthcare conference, being held november 29 – december 2, 2021. the company will also host investor meetings during the conference.
MTNB Ratings Summary
MTNB Quant Ranking